AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36326664 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment Foster Care Oregon (TFCO)
Number of subjects: 166
Study 33175627 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralised oxidised regenerated cellulose (NORC)
Number of subjects: 236
Study 33175627 — intervention group
Group type: COMPARATOR
Intervention: Oxidised regenerated cellulose (ORC)
Number of subjects: 236
Study 33962041 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (TAF), n = 87
Number of subjects: 174
Study 33962041 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir disoproxil fumarate (TDF), n = 87
Number of subjects: 174
Study 35710235 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored exercise and manual therapy
Number of subjects: 28
Study 35710235 — intervention group
Group type: COMPARATOR
Intervention: Standardised exercise
Number of subjects: 28
Study 35394821 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors
Number of subjects: 49875
Study 33259688 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus brevis CD2 (4 billion colony‐forming units after breakfast, lunch, and dinner for 21 days)
Number of subjects: 20
Study 33259688 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus brevis CD2
Number of subjects: 20
Study 33259688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 33259688 — intervention group
Group type: COMPARATOR
Intervention: Lactobacillus brevis CD2 and Placebo
Number of subjects: 20
Study 32187150 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 0
Study 32187150 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 0
Study 32187150 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Training (CT)
Number of subjects: 0
Study 32187150 — intervention group
Group type: COMPARATOR
Intervention: Nutritional Guidance (NG)
Number of subjects: 0
Study 33673568 — intervention group
Group type: EXPERIMENTAL
Intervention: fortified sachet (vitamin D and calcium) and powdered milk plus periodontal therapy during pregnancy (early PT) (n = 17)
Number of subjects: 69
Study 33673568 — intervention group
Group type: COMPARATOR
Intervention: placebo sachet and powdered milk plus early PT (n = 15)
Number of subjects: 69
Study 33673568 — intervention group
Group type: EXPERIMENTAL
Intervention: fortified sachet and powdered milk plus late PT (after delivery) (n = 19)
Number of subjects: 69
Study 33673568 — intervention group
Group type: COMPARATOR
Intervention: placebo sachet and powdered milk plus late PT (n = 18)
Number of subjects: 69
Study 32111770 — intervention group
Group type: COMPARATOR
Intervention: TACE (chemoembolization with irinotecan)
Number of subjects: 30
Study 32111770 — intervention group
Group type: EXPERIMENTAL
Intervention: TACE-B (chemoembolization with irinotecan followed by bevacizumab)
Number of subjects: 30
Study 33836382 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 0
Study 33836382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35585153 — intervention group
Group type: COMPARATOR
Intervention: A: no further interventions
Number of subjects: 1209
Study 35585153 — intervention group
Group type: EXPERIMENTAL
Intervention: E: MEM + NFS + TE
Number of subjects: 1209
Study 32640286 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of meditation training
Number of subjects: 0
Study 32640286 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study 36057652 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine-derived collagen matrix (PDCM) using modified coronally advanced tunnel (MCAT) technique
Number of subjects: 28
Study 36057652 — intervention group
Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (SCTG) using modified coronally advanced tunnel (MCAT) technique
Number of subjects: 28
Study 34690787 — intervention group
Group type: EXPERIMENTAL
Intervention: OV101 5 mg QD (n = 8)
Number of subjects: 23
Study 34690787 — intervention group
Group type: EXPERIMENTAL
Intervention: OV101 5 mg BID (n = 8)
Number of subjects: 23
Study 34690787 — intervention group
Group type: EXPERIMENTAL
Intervention: OV101 5 mg TID (n = 7)
Number of subjects: 23
Study 34690787 — intervention group
Group type: EXPERIMENTAL
Intervention: OV101 (all doses)
Number of subjects: 23
Study 35400537 — intervention group
Group type: EXPERIMENTAL
Intervention: aboBoNT‐A 600 U
Number of subjects: 485
Study 35400537 — intervention group
Group type: EXPERIMENTAL
Intervention: aboBoNT‐A 800 U
Number of subjects: 485
Study 35400537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 485
Study 35400537 — intervention group
Group type: EXPERIMENTAL
Intervention: aboBoNT‐A 600 U and 800 U
Number of subjects: 485
Study 36123073 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 22
Study 36123073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 34875669 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-session group-based program based on behavioural principles
Number of subjects: 240
Study 34875669 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 240
Study 33635903 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifting unknown weights
Number of subjects: 10
Study 33635903 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifting unknown lightweights
Number of subjects: 10
Study 32545478 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g of cocoa-rich chocolate (99% cocoa) daily for six months
Number of subjects: 140
Study 32545478 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 140
Study 35929990 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin C (1.5 g/kg/d, intravenously for 3 hours from D1 to D3) plus FOLFOX ± bevacizumab
Number of subjects: 442
Study 35929990 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX ± bevacizumab (Control)
Number of subjects: 442
Study 35929990 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin C plus FOLFOX ± bevacizumab
Number of subjects: 442
Study 35929990 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin C plus chemotherapy
Number of subjects: 442
Study 35929990 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy only (Control)
Number of subjects: 442
Study 32274554 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI+WHR- PGS
Number of subjects: 692
Study 32274554 — intervention group
Group type: EXPERIMENTAL
Intervention: WHRonly+ PGS with average-protein diet
Number of subjects: 692
Study 32274554 — intervention group
Group type: EXPERIMENTAL
Intervention: WHRonly+ PGS with high-protein diet
Number of subjects: 692
Study 32631387 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupuncture stimulation (TEAS) at L14 and PC6, ST36 and ST37.
Number of subjects: 280
Study 32631387 — intervention group
Group type: COMPARATOR
Intervention: Sham group receiving pseudo-TEAS at sham acupoints.
Number of subjects: 280
Study 35560696 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 464
Study 35560696 — intervention group
Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 464
Study 33208593 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher CysC concentration (≥0.78mg/L) in patients with higher hsCRP concentrations (≥4.8ng/mL)
Number of subjects: 3474
Study 33208593 — intervention group
Group type: EXPERIMENTAL
Intervention: CysC
Number of subjects: 3474
Study 32025848 — intervention group
Group type: EXPERIMENTAL
Intervention: KRM-20 combined with docetaxel and dexamethasone
Number of subjects: 51
Study 32025848 — intervention group
Group type: COMPARATOR
Intervention: Placebo with docetaxel and dexamethasone
Number of subjects: 51
Study 36251874 — intervention group
Group type: EXPERIMENTAL
Intervention: Babble Boot Camp (BBC)
Number of subjects: 16
Study 33287642 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate observational caffeine intake from coffee (121 to 180 mg/day)
Number of subjects: 407072
Study 33287642 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate observational caffeine intake from coffee (301 to 360 mg/day)
Number of subjects: 407072
Study 33287642 — intervention group
Group type: COMPARATOR
Intervention: Genetically determined caffeine intake
Number of subjects: 407072
Study 36419020 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for 2 months
Number of subjects: 461
Study 36419020 — intervention group
Group type: COMPARATOR
Intervention: Routine follow-up
Number of subjects: 461
Study 33831589 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral opioids as labor analgesia
Number of subjects: 1404
Study 32802108 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycyrrhiza glabra syrup (5 cc, two times a day)
Number of subjects: 60
Study 32802108 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (400 mg tablets every 8 hours)
Number of subjects: 60
Study 36107549 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided serratus anterior plane block (SAPB) with 20 mL of 0.25% bupivacaine + general anesthesia
Number of subjects: 44
Study 36107549 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia only (control group)
Number of subjects: 44
Study 36107549 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided serratus anterior plane block (SAPB)
Number of subjects: 44
Study 34016158 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives contingent on low alcohol use
Number of subjects: 680
Study 34016158 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives contingent on high adherence to INH
Number of subjects: 680
Study 34016158 — intervention group
Group type: EXPERIMENTAL
Intervention: Escalating financial incentives for both decreasing alcohol use and increasing adherence to INH
Number of subjects: 680
Study 34016158 — intervention group
Group type: COMPARATOR
Intervention: No incentives (control)
Number of subjects: 680
Study 32723669 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade +IV inferior shoulder mobilization, 3 sets, 60 seconds
Number of subjects: 22
Study 32723669 — intervention group
Group type: COMPARATOR
Intervention: Control condition (not specified)
Number of subjects: 22
Study 36272898 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-tIPNS
Number of subjects: 30
Study 36272898 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study 33772851 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal trans-spinal direct current stimulation (tsDCS)
Number of subjects: 16
Study 33772851 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal trans-spinal direct current stimulation (tsDCS)
Number of subjects: 16
Study 33772851 — intervention group
Group type: COMPARATOR
Intervention: Sham trans-spinal direct current stimulation (tsDCS)
Number of subjects: 16
Study 33772851 — intervention group
Group type: EXPERIMENTAL
Intervention: Both active tsDCS conditions
Number of subjects: 16
Study 32580914 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency rTMS over the right DLPFC (10 Hz; 110% resting motor threshold; 60 trains with 50 pulses)
Number of subjects: 19
Study 32580914 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 19
Study 32580914 — intervention group
Group type: COMPARATOR
Intervention: High-frequency rTMS over the left DLPFC (10 Hz; 110% resting motor threshold; 60 trains with 50 pulses)
Number of subjects: 19
Study 34749410 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced Salt Solution (BSS)
Number of subjects: 96
Study 34749410 — intervention group
Group type: COMPARATOR
Intervention: Air Tamponade
Number of subjects: 96
Study 36471301 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual simulation system training (Group V)
Number of subjects: 19
Study 36471301 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaw simulation model training (Group J)
Number of subjects: 19
Study 36471301 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaw model training followed by virtual system training (Group J-V)
Number of subjects: 19
Study 36471301 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual system followed by jaw model training (Group V-J)
Number of subjects: 19
Study 36471301 — intervention group
Group type: COMPARATOR
Intervention: Questionnaire survey results
Number of subjects: 19
Study 32875933 — intervention group
Group type: EXPERIMENTAL
Intervention: Matcha green tea powder (3x1 gram capsules per day for three weeks)
Number of subjects: 12
Study 32875933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 33428281 — intervention group
Group type: EXPERIMENTAL
Intervention: Risankizumab 150 mg subcutaneous injections at weeks 0, 4, and 16
Number of subjects: 120
Study 33428281 — intervention group
Group type: COMPARATOR
Intervention: Fumaric acid esters (FAEs)
Number of subjects: 120
Study 33428281 — intervention group
Group type: EXPERIMENTAL
Intervention: Risankizumab
Number of subjects: 120
Study 32610971 — intervention group
Group type: EXPERIMENTAL
Intervention: Formation of the parent C4F7N‐ anion at energies close to 0 eV
Number of subjects: 0
Study 32610971 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical evaporation of the F‐atom leading to the defluorinated anion C4F6N‐
Number of subjects: 0
Study 32610971 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissociative electron attachment leading to several resonances and fragments
Number of subjects: 0
Study 35584738 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming (EXE)
Number of subjects: 70
Study 35584738 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance (BAL)
Number of subjects: 70
Study 35584738 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling (CYC)
Number of subjects: 70
Study 35584738 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation (PNF)
Number of subjects: 70
Study 35584738 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 70
Study 33241266 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine with rifapentine/isoniazid
Number of subjects: 78
Study 32112738 — intervention group
Group type: EXPERIMENTAL
Intervention: Camrelizumab 3 mg/kg intravenously every 2 or 3 weeks
Number of subjects: 217
Study 35830342 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion
Number of subjects: 0
Study 35830342 — intervention group
Group type: COMPARATOR
Intervention: Open Radical Cystectomy
Number of subjects: 0
Study 34992667 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol 0.02 mg/kg
Number of subjects: 60
Study 34992667 — intervention group
Group type: COMPARATOR
Intervention: Tramadol 1.5 mg/kg
Number of subjects: 60
Study 32554688 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple risk behaviour intervention (individual sessions, group sessions, communitarian activities, SMS reception)
Number of subjects: 3067
Study 32554688 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3067
Study 32439957 — intervention group
Group type: EXPERIMENTAL
Intervention: IV acetaminophen
Number of subjects: 86
Study 32439957 — intervention group
Group type: COMPARATOR
Intervention: IV indomethacin
Number of subjects: 86
Study 32933867 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating Disorder Examination (EDE) original 4 subscales
Number of subjects: 20
Study 32933867 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating Disorder Examination (EDE) alternative brief 3 subscales
Number of subjects: 20
Study 32933867 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric loss-of-control eating episodes
Number of subjects: 20
Study 32933867 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric overeating episodes
Number of subjects: 20
Study 35098674 — intervention group
Group type: EXPERIMENTAL
Intervention: LCL161 monotherapy (1200 mg)
Number of subjects: 9
Study 35098674 — intervention group
Group type: EXPERIMENTAL
Intervention: LCL161 plus paclitaxel (80 mg/m2)
Number of subjects: 9
Study 35098674 — intervention group
Group type: COMPARATOR
Intervention: LCL161 monotherapy
Number of subjects: 9
Study 32563598 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-discharge oral nutritional supplements (ONS) with dietary advice
Number of subjects: 353
Study 32563598 — intervention group
Group type: COMPARATOR
Intervention: Dietary advice alone (control)
Number of subjects: 353
Study 32384415 — intervention group
Group type: EXPERIMENTAL
Intervention: Conscious thought (CT) for 2 minutes
Number of subjects: 121
Study 32384415 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconscious thought (UT) for 2 minutes
Number of subjects: 121
Study 32384415 — intervention group
Group type: COMPARATOR
Intervention: Immediate decision making
Number of subjects: 121
Study 34494355 — intervention group
Group type: EXPERIMENTAL
Intervention: PMI defined by SYNTAX definition
Number of subjects: 1300
Study 34494355 — intervention group
Group type: EXPERIMENTAL
Intervention: PMI defined by 4th UDMI definition
Number of subjects: 1300
Study 34494355 — intervention group
Group type: EXPERIMENTAL
Intervention: PMI defined by ISCHEMIA definition
Number of subjects: 1300
Study 34494355 — intervention group
Group type: EXPERIMENTAL
Intervention: PMI defined by SCAI definition
Number of subjects: 1300
Study 34494355 — intervention group
Group type: EXPERIMENTAL
Intervention: PMI defined by EXCEL definition
Number of subjects: 1300
Study 36143921 — intervention group
Group type: COMPARATOR
Intervention: 2% chlorhexidine (CHX)
Number of subjects: 100
Study 36143921 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (NaOCl)
Number of subjects: 100
Study 36143921 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% ethylenediaminetetraacetate acid (EDTA)
Number of subjects: 100
Study 36143921 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% povidone iodine (PVI)
Number of subjects: 100
Study 36143921 — intervention group
Group type: COMPARATOR
Intervention: Control group (CNT)
Number of subjects: 100
Study 33041014 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated closed-loop vasopressor (CLV) controller
Number of subjects: 30
Study 33041014 — intervention group
Group type: COMPARATOR
Intervention: Manual adjustment of norepinephrine infusion (Control)
Number of subjects: 30
Study 33205662 — intervention group
Group type: EXPERIMENTAL
Intervention: Durable Polymer Drug-Eluting Stent (DP-DES)
Number of subjects: 3413
Study 33205662 — intervention group
Group type: COMPARATOR
Intervention: Biodegradable Polymer Drug-Eluting Stent (BP-DES)
Number of subjects: 3413
Study 32100888 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive relational aggression
Number of subjects: 421
Study 32100888 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive relational aggression
Number of subjects: 421
Study 32100888 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive physical aggression
Number of subjects: 421
Study 32100888 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive physical aggression
Number of subjects: 421
Study 33724919 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-based sentiment analysis of social media posts
Number of subjects: 300000
Study 32002556 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose radiation (64.8 Gy in 36 fractions)
Number of subjects: 203
Study 32002556 — intervention group
Group type: COMPARATOR
Intervention: Low-dose radiation (50.4 Gy in 28 fractions)
Number of subjects: 203
Study 32002556 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal MMSE at baseline
Number of subjects: 203
Study 33012596 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA with PSI monitoring (group P-PSI)
Number of subjects: 120
Study 33012596 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA without PSI monitoring (group P)
Number of subjects: 120
Study 33012596 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane with PSI monitoring (group D-PSI)
Number of subjects: 120
Study 33012596 — intervention group
Group type: COMPARATOR
Intervention: Desflurane without PSI monitoring (group D)
Number of subjects: 120
Study 33138837 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT
Number of subjects: 6
Study 33138837 — intervention group
Group type: EXPERIMENTAL
Intervention: VMAT
Number of subjects: 6
Study 33138837 — intervention group
Group type: EXPERIMENTAL
Intervention: Helical Tomotherapy (HT)
Number of subjects: 6
Study 36164038 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP + tafasitamab (12 mg/kg intravenously, Days 1, 8, and 15) + LEN (25 mg orally, Days 1-10)
Number of subjects: 880
Study 36164038 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP + tafasitamab + LEN placebos
Number of subjects: 880
Study 34428259 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support programs
Number of subjects: 22
Study 35365180 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPP approach (nutrition education and SBC)
Number of subjects: 900
Study 35365180 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPP+ approach (NIPP + agricultural inputs, training, and tools)
Number of subjects: 900
Study 35365180 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 900
Study 35939577 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental vitamin D3 (2000 IU per day)
Number of subjects: 25871
Study 35939577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25871
Study 32394049 — intervention group
Group type: EXPERIMENTAL
Intervention: KiVa antibullying program
Number of subjects: 4383
Study 32394049 — intervention group
Group type: EXPERIMENTAL
Intervention: KiVa+ (KiVa with additional network feedback to teachers)
Number of subjects: 4383
Study 32394049 — intervention group
Group type: COMPARATOR
Intervention: Control condition (waiting list, care as usual)
Number of subjects: 4383
Study 35594968 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Blood Pressure Reduction (MB-BP) program
Number of subjects: 36
Study 35594968 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 33035731 — intervention group
Group type: EXPERIMENTAL
Intervention: CEASE intervention
Number of subjects: 725
Study 33035731 — intervention group
Group type: COMPARATOR
Intervention: Usual Care Control (UCC)
Number of subjects: 725
Study 33792210 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment (oral hygiene instructions, scaling and root planing)
Number of subjects: 82